BE Ventures Leads AcroCyte Therapeutics’ US$10 Million Financing Round to Accelerate Clinical Translation of the R³CE® Platform and U.S. Expansion 2026年8月26日 Professor Ying-Chih Chang 詳しく見る »
From FDA Clearance to Organ Transplantation: ANIVIA’s U.S. Commercialization Pathway for Taiwan’s Therapeutic MedTech 2026年8月20日 Henry Lin, Co-founder and 詳しく見る »
After Passing Innovation Board Review, H2U Receives Investment from BE Health Ventures and Partners to Establish a Corporate Accelerator for Digital Health 2026年8月19日 Because healthcare and di 詳しく見る »
